EarlyCap

Portfolio · 1

BioProtect

Developer of a biodegradable balloon implant for prostate cancer radiation therapy.

3 rounds $2.2M committed Latest: 2016-06

Investment activity

1 portfolio exit on record.

Q&A

What is EarlyCap's most notable exit?

EarlyCap's most notable exit is BioProtect, which was acquired by Almeda Ventures for $200M in January 2026.

What sectors does EarlyCap focus on for investments?

EarlyCap shows a concentration in the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.

Can you name a key company in EarlyCap's portfolio?

A key company in EarlyCap's portfolio is BioProtect, which develops biodegradable balloons for safe radiation therapy.

What is the typical investment stage for EarlyCap?

EarlyCap has participated in both A Round and B Round investments, including follow-on rounds.

When was EarlyCap most active in making new investments?

EarlyCap's new portfolio company activity includes an investment in February 2006.

What is the most recent exit for EarlyCap?

EarlyCap's most recent exit was BioProtect in January 2026.